and include the spectrum of the relatively chemotherapy-sensitive anaplastic oligodendrogliomas (AOs), the more chemotherapy refractory anaplastic astrocytomas (AAs) and mixed oligoastrocytomas ...

One of the most striking differences was the expression of normal brain genes by oligodendrogliomas with 1p19q codeletion. These gliomas harbored a gene expression profile that partially resembled ...

A total of 58% of patients with malignant astrocytomas achieved a complete or partial response to therapy, but only partial responses were noted in anaplastic oligodendroglioma patients (52%).